Скачать или смотреть Advanced Therapies Week 2025: Considering the End Early

Considering the End Early: Planning for CGT Success from the Start | ATW 2025

Success in cell therapy manufacturing starts with early strategic planning. This session explores the key process decisions that can set up long-term success.

💡 Key Takeaways:
🔹 Donna Rill on why end-stage planning should start on Day 1
🔹 David Hermanson on how closed systems future-proof manufacturing
🔹 Kasia Averall on leveraging feedback loops in autologous therapies
🔹 Scott Jones on early potency assay development

Speakers:
🔹 Arnaud Deladeriere – President, Cell&Gene Consulting Inc. (Chair)
🔹 Donna Rill – CTO, Triumvira Immunologics
🔹 David Hermanson – Principal Scientist, Bio-Techne
🔹 Kasia Averall – VP of Quality, Quell Therapeutics
🔹 Scott Jones – SVP & CSO, BioBridge Global

🎟️ Future-proof your biotech strategy at ATW 2026!
🔹 Pre-register now → https://ow.ly/5Ssp50Vaotw
📖 Download the ATW 2025 Show Brochure → https://ow.ly/raF450Vaouz

#ATW26 #CellTherapy #Manufacturing #AdvancedTherapies #FutureOfBiotech